These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11026022)

  • 1. [Staging and prognosis of breast cancer].
    Fukuuchi A
    Nihon Rinsho; 2000 Apr; 58 Suppl():383-94. PubMed ID: 11026022
    [No Abstract]   [Full Text] [Related]  

  • 2. ["Prognostic factors" in breast cancer--1].
    Brockmann B; Reitzig P
    Z Arztl Fortbild (Jena); 1994 Feb; 88(2):111-4. PubMed ID: 8147017
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multi-modal treatment in breast cancer. The prognostic role and correlation between relapse and metastasis].
    Munteanu A; Munteanu F; Bild E
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):941-6. PubMed ID: 20191859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
    Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
    Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of nuclear morphology in breast cancer prognosis.
    Wolberg WH; Street WN; Mangasarian OL
    Clin Cancer Res; 1999 Nov; 5(11):3542-8. PubMed ID: 10589770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to breast-cancer staging.
    Smith BL
    N Engl J Med; 2000 Feb; 342(8):580-1. PubMed ID: 10684918
    [No Abstract]   [Full Text] [Related]  

  • 7. The epidemiology of tumor markers in breast cancer management: prognostic markers.
    Page DL
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):101-4. PubMed ID: 8049630
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer of the breast in young women.
    Molnár L; Besznyák I; Köves I
    Acta Chir Hung; 1995-1996; 35(1-2):5-11. PubMed ID: 8659239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical importance of histology, grading and ploidies in primary breast cancer].
    Schlotter CM; Kropp S; Wichert S; Vogt U; Krieg V; Bosse U; Wassmann K
    Zentralbl Gynakol; 1999; 121(8):384-8. PubMed ID: 10486881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of postoperative pregnancy upon prognosis of young breast cancer patients].
    Wu JY; Chen CM; Zhang JX; Hou YF; Hu Z; Liu GY; Di GH; Wu J; Lu JS; Shen KW; Shao ZM; Shen ZZ
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3126-9. PubMed ID: 20193275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating soluble Fas concentration in breast cancer patients.
    Ueno T; Toi M; Tominaga T
    Clin Cancer Res; 1999 Nov; 5(11):3529-33. PubMed ID: 10589768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis].
    Li HX; Zh S; Zhang YH; Risberg B; Karlsson MG; Nesland JM
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):669-72. PubMed ID: 15777505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.
    Lackowska B; Niezabitowski A; Ryś J; Skołyszewski J; Stelmach A; Gruchała A; Jaszcz-Gruchała A
    Pol J Pathol; 2003; 54(2):101-10. PubMed ID: 14575418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of prognostic factors in evaluation of survival in breast cancer].
    Popârlan T; Muscă S
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):147-51. PubMed ID: 20509292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical classification of extent of disease in cancer of the breast.
    Cutler SJ; Myers MH
    J Natl Cancer Inst; 1967 Aug; 39(2):193-207. PubMed ID: 18623939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bel-2 as a prognostic factor of breast cancers].
    Watanabe K; Kawabata K; Ozaki S; Fujita H; Kojima Y; Tsuda H
    Nihon Rinsho; 2000 Apr; 58 Suppl():423-8. PubMed ID: 11026028
    [No Abstract]   [Full Text] [Related]  

  • 19. [Factors in the prognosis in breast cancer].
    Ostrovtsev LD
    Khirurgiia (Mosk); 1979 Jun; (6):92-6. PubMed ID: 449246
    [No Abstract]   [Full Text] [Related]  

  • 20. [-Breast neoplasms: axillary lymph node excision--at what price-].
    Rageth JC
    Arch Gynecol Obstet; 1995; 256 Suppl():S85-92. PubMed ID: 8619667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.